Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Novel Radiomic Features based on Joint Intensity Matrices for Predicting Glioblastoma Patient Survival Time.

Chaddad A, Daniel P, Desrosiers C, Toews M, Abdulkarim B.

IEEE J Biomed Health Inform. 2018 Apr 9. doi: 10.1109/JBHI.2018.2825027. [Epub ahead of print]

PMID:
29993848
2.

Prediction of survival with multi-scale radiomic analysis in glioblastoma patients.

Chaddad A, Sabri S, Niazi T, Abdulkarim B.

Med Biol Eng Comput. 2018 Jun 19. doi: 10.1007/s11517-018-1858-4. [Epub ahead of print]

PMID:
29915951
3.

Response to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer.

Oweida A, Sabri S, Al-Rabea A, Ebrahimi M, Ruo R, Fraser R, Seuntjens J, Abdulkarim B.

Oncotarget. 2017 Nov 28;9(2):1630-1640. doi: 10.18632/oncotarget.22727. eCollection 2018 Jan 5.

4.

Prognostic factors for progression in atypical meningioma.

Shakir SI, Souhami L, Petrecca K, Mansure JJ, Singh K, Panet-Raymond V, Shenouda G, Al-Odaini AA, Abdulkarim B, Guiot MC.

J Neurosurg. 2018 Jan 19:1-9. doi: 10.3171/2017.6.JNS17120. [Epub ahead of print]

PMID:
29350599
5.

Predicting survival time of lung cancer patients using radiomic analysis.

Chaddad A, Desrosiers C, Toews M, Abdulkarim B.

Oncotarget. 2017 Nov 1;8(61):104393-104407. doi: 10.18632/oncotarget.22251. eCollection 2017 Nov 28.

6.

CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.

Kaur S, Ramdzan ZM, Guiot MC, Li L, Leduy L, Ramotar D, Sabri S, Abdulkarim B, Nepveu A.

Neuro Oncol. 2018 Mar 27;20(4):484-493. doi: 10.1093/neuonc/nox178.

PMID:
29036362
7.

Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.

Garnier D, Meehan B, Kislinger T, Daniel P, Sinha A, Abdulkarim B, Nakano I, Rak J.

Neuro Oncol. 2018 Jan 22;20(2):236-248. doi: 10.1093/neuonc/nox142.

PMID:
29016925
8.

Performance of Knowledge-Based Radiation Therapy Planning for the Glioblastoma Disease Site.

Chatterjee A, Serban M, Abdulkarim B, Panet-Raymond V, Souhami L, Shenouda G, Sabri S, Jean-Claude B, Seuntjens J.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):1021-1028. doi: 10.1016/j.ijrobp.2017.07.012. Epub 2017 Jul 14.

PMID:
28870791
9.

High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer.

Gupta N, Jung K, Wu C, Alshareef A, Alqahtani H, Damaraju S, Mackey JR, Ghosh S, Sabri S, Abdulkarim BS, Bigras G, Lai R.

Oncotarget. 2017 Apr 25;8(17):28101-28115. doi: 10.18632/oncotarget.15891.

10.

Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.

Azoulay M, Santos F, Shenouda G, Petrecca K, Oweida A, Guiot MC, Owen S, Panet-Raymond V, Souhami L, Abdulkarim BS.

J Neurooncol. 2017 May;132(3):419-426. doi: 10.1007/s11060-017-2383-2. Epub 2017 Apr 3.

PMID:
28374095
11.

Guanabenz Sensitizes Pancreatic β Cells to Lipotoxic Endoplasmic Reticulum Stress and Apoptosis.

Abdulkarim B, Hernangomez M, Igoillo-Esteve M, Cunha DA, Marselli L, Marchetti P, Ladriere L, Cnop M.

Endocrinology. 2017 Jun 1;158(6):1659-1670. doi: 10.1210/en.2016-1773.

PMID:
28323924
12.

A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma.

Shenouda G, Souhami L, Petrecca K, Owen S, Panet-Raymond V, Guiot MC, Corredor AG, Abdulkarim B.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):487-494. doi: 10.1016/j.ijrobp.2016.11.006. Epub 2016 Nov 15.

PMID:
28011051
13.

Ablative versus fractionated radiation therapy: a controversial role in cancer invasion and metastasis.

Oweida A, Abdulkarim B.

Oncogene. 2016 Nov 10;35(45):5928-5929. doi: 10.1038/onc.2016.130. Epub 2016 Apr 25. No abstract available.

PMID:
27109097
14.

Differential response to ablative ionizing radiation in genetically distinct non-small cell lung cancer cells.

Oweida A, Sharifi Z, Halabi H, Xu Y, Sabri S, Abdulkarim B.

Cancer Biol Ther. 2016 Apr 2;17(4):390-9. doi: 10.1080/15384047.2016.1139241.

15.

A Missense Mutation in PPP1R15B Causes a Syndrome Including Diabetes, Short Stature, and Microcephaly.

Abdulkarim B, Nicolino M, Igoillo-Esteve M, Daures M, Romero S, Philippi A, Senée V, Lopes M, Cunha DA, Harding HP, Derbois C, Bendelac N, Hattersley AT, Eizirik DL, Ron D, Cnop M, Julier C.

Diabetes. 2015 Nov;64(11):3951-62. doi: 10.2337/db15-0477. Epub 2015 Jul 9.

16.

Elevated ARG1 expression in primary monocytes-derived macrophages as a predictor of radiation-induced acute skin toxicities in early breast cancer patients.

Jung K, Sabri S, Hanson J, Xu Y, Wang YW, Lai R, Abdulkarim BS.

Cancer Biol Ther. 2015;16(9):1281-8. doi: 10.1080/15384047.2015.1056945.

17.

Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution.

Azoulay M, Santos F, Souhami L, Panet-Raymond V, Petrecca K, Owen S, Guiot MC, Patyka M, Sabri S, Shenouda G, Abdulkarim B.

Radiat Oncol. 2015 Apr 26;10:106. doi: 10.1186/s13014-015-0396-6.

18.

Triple negative breast cancers comprise a highly tumorigenic cell subpopulation detectable by its high responsiveness to a Sox2 regulatory region 2 (SRR2) reporter.

Jung K, Gupta N, Wang P, Lewis JT, Gopal K, Wu F, Ye X, Alshareef A, Abdulkarim BS, Douglas DN, Kneteman NM, Lai R.

Oncotarget. 2015 Apr 30;6(12):10366-73.

19.

Unveiling a common mechanism of apoptosis in β-cells and neurons in Friedreich's ataxia.

Igoillo-Esteve M, Gurgul-Convey E, Hu A, Romagueira Bichara Dos Santos L, Abdulkarim B, Chintawar S, Marselli L, Marchetti P, Jonas JC, Eizirik DL, Pandolfo M, Cnop M.

Hum Mol Genet. 2015 Apr 15;24(8):2274-86. doi: 10.1093/hmg/ddu745. Epub 2014 Dec 30.

PMID:
25552656
20.

Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays.

Jung K, Wang P, Gupta N, Gopal K, Wu F, Ye X, Alshareef A, Bigras G, McMullen TP, Abdulkarim BS, Lai R.

Breast Cancer Res. 2014 Nov 8;16(6):470. doi: 10.1186/s13058-014-0470-2.

21.

YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells.

Jung K, Wu F, Wang P, Ye X, Abdulkarim BS, Lai R.

BMC Cancer. 2014 May 9;14:328. doi: 10.1186/1471-2407-14-328.

22.

Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas.

Lecavalier-Barsoum M, Quon H, Abdulkarim B.

Cochrane Database Syst Rev. 2014 May 15;(5):CD007104. doi: 10.1002/14651858.CD007104.pub2. Review.

PMID:
24833028
23.

RalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC).

Ezzeldin M, Borrego-Diaz E, Taha M, Esfandyari T, Wise AL, Peng W, Rouyanian A, Asvadi Kermani A, Soleimani M, Patrad E, Lialyte K, Wang K, Williamson S, Abdulkarim B, Olyaee M, Farassati F.

Mol Oncol. 2014 Jul;8(5):1043-53. doi: 10.1016/j.molonc.2014.03.020. Epub 2014 Apr 13.

24.

A Phase I Study of Tomotherapy in Patients With Primary Benign and Low-grade Brain Tumors: Late Toxicity and Quality of Life.

Boychak A, Bauman G, Fisher B, Abdulkarim B, Amanie J, Fulton D, Murtha A, Patel S, Urtasun R, Ghosh S, Roa WH.

Am J Clin Oncol. 2016 Apr;39(2):160-6. doi: 10.1097/COC.0000000000000034.

PMID:
24457533
25.

RNA sequencing identifies dysregulation of the human pancreatic islet transcriptome by the saturated fatty acid palmitate.

Cnop M, Abdulkarim B, Bottu G, Cunha DA, Igoillo-Esteve M, Masini M, Turatsinze JV, Griebel T, Villate O, Santin I, Bugliani M, Ladriere L, Marselli L, McCarthy MI, Marchetti P, Sammeth M, Eizirik DL.

Diabetes. 2014 Jun;63(6):1978-93. doi: 10.2337/db13-1383. Epub 2013 Dec 30.

26.

tRNA methyltransferase homolog gene TRMT10A mutation in young onset diabetes and primary microcephaly in humans.

Igoillo-Esteve M, Genin A, Lambert N, Désir J, Pirson I, Abdulkarim B, Simonis N, Drielsma A, Marselli L, Marchetti P, Vanderhaeghen P, Eizirik DL, Wuyts W, Julier C, Chakera AJ, Ellard S, Hattersley AT, Abramowicz M, Cnop M.

PLoS Genet. 2013 Oct;9(10):e1003888. doi: 10.1371/journal.pgen.1003888. Epub 2013 Oct 31.

27.

Risk-based long-term screening for hepatocellular carcinoma recurrence after living donor liver transplantation.

Hwang S, Moon DB, Ahn CS, Kim KH, Ha TY, Song GW, Jung DH, Park GC, Lee HC, Lee YS, Chung YH, Abdulkarim BA, Lee SG.

Transplant Proc. 2013 Oct;45(8):3076-84. doi: 10.1016/j.transproceed.2013.08.068.

PMID:
24157040
28.

Spontaneous epithelial-mesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer.

Lesniak D, Sabri S, Xu Y, Graham K, Bhatnagar P, Suresh M, Abdulkarim B.

PLoS One. 2013 Aug 26;8(8):e71987. doi: 10.1371/journal.pone.0071987. eCollection 2013.

29.

Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.

Jastaniyah N, Murtha A, Pervez N, Le D, Roa W, Patel S, Mackenzie M, Fulton D, Field C, Ghosh S, Fallone G, Abdulkarim B.

Radiat Oncol. 2013 Feb 20;8:38. doi: 10.1186/1748-717X-8-38.

30.

Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation.

Zeng Z, Ren J, O'Neil M, Zhao J, Bridges B, Cox J, Abdulkarim B, Schmitt TM, Kumer SC, Weinman SA.

BMC Cancer. 2012 Dec 7;12:584. doi: 10.1186/1471-2407-12-584.

31.

O6-Methylguanine-DNA methyltransferase is a novel negative effector of invasion in glioblastoma multiforme.

Chahal M, Abdulkarim B, Xu Y, Guiot MC, Easaw JC, Stifani N, Sabri S.

Mol Cancer Ther. 2012 Nov;11(11):2440-50. doi: 10.1158/1535-7163.MCT-11-0977. Epub 2012 Sep 17.

32.

Skin-sparing helical tomotherapy vs 3D-conformal radiotherapy for adjuvant breast radiotherapy: in vivo skin dosimetry study.

Capelle L, Warkentin H, Mackenzie M, Joseph K, Gabos Z, Pervez N, Tankel K, Chafe S, Amanie J, Ghosh S, Parliament M, Abdulkarim B.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e583-90. doi: 10.1016/j.ijrobp.2012.01.086. Epub 2012 May 12.

PMID:
22580119
33.

Changes in serial magnetic resonance spectroscopy predict outcome in high-grade glioma during and after postoperative radiotherapy.

Quon H, Brunet B, Alexander A, Murtha A, Abdulkarim B, Fulton D, Smerdely M, Johnson M, Urtasun R, Patel S, Ghosh S, Roa W.

Anticancer Res. 2011 Oct;31(10):3559-65.

PMID:
21965778
34.

Alteration of hepatic nuclear receptor-mediated signaling pathways in hepatitis C virus patients with and without a history of alcohol drinking.

Wu C, Gilroy R, Taylor R, Olyaee M, Abdulkarim B, Forster J, O'Neil M, Damjanov I, Wan YJ.

Hepatology. 2011 Dec;54(6):1966-74. doi: 10.1002/hep.24645.

35.

Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma.

Polireddy K, Chavan H, Abdulkarim BA, Krishnamurthy P.

Mol Oncol. 2011 Oct;5(5):410-25. doi: 10.1016/j.molonc.2011.07.005. Epub 2011 Jul 28.

36.

Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.

Abdulkarim BS, Cuartero J, Hanson J, Deschênes J, Lesniak D, Sabri S.

J Clin Oncol. 2011 Jul 20;29(21):2852-8. doi: 10.1200/JCO.2010.33.4714. Epub 2011 Jun 13.

37.

Blood group A isoagglutinins in A(2) → O simultaneous liver/kidney transplantation may not influence kidney function.

Bryan CF, Abdulkarim B, Nawabi A, Stewart D, Yarlagadda SG.

Am J Transplant. 2011 Jul;11(7):1527-30. doi: 10.1111/j.1600-6143.2011.03575.x. Epub 2011 Jun 10.

38.

The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer.

Gabos Z, Thoms J, Ghosh S, Hanson J, Deschênes J, Sabri S, Abdulkarim B.

Breast Cancer Res Treat. 2010 Nov;124(1):187-94. doi: 10.1007/s10549-010-1135-1. Epub 2010 Sep 3.

PMID:
20814819
39.

Metabolic modulation of glioblastoma with dichloroacetate.

Michelakis ED, Sutendra G, Dromparis P, Webster L, Haromy A, Niven E, Maguire C, Gammer TL, Mackey JR, Fulton D, Abdulkarim B, McMurtry MS, Petruk KC.

Sci Transl Med. 2010 May 12;2(31):31ra34. doi: 10.1126/scitranslmed.3000677.

40.

A new role for the virtual crossmatch in kidney allograft reuse.

Bryan CF, Abdulkarim B, Forster J, Nelson PW, Diederich D, Murillo D, Markham L.

Transplantation. 2010 Mar 27;89(6):764-5. doi: 10.1097/TP.0b013e3181c9025d. No abstract available.

PMID:
20308864
41.

Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer.

Graesslin O, Abdulkarim BS, Coutant C, Huguet F, Gabos Z, Hsu L, Marpeau O, Uzan S, Pusztai L, Strom EA, Hortobagyi GN, Rouzier R, Ibrahim NK.

J Clin Oncol. 2010 Apr 20;28(12):2032-7. doi: 10.1200/JCO.2009.24.6314. Epub 2010 Mar 22.

PMID:
20308667
42.

MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.

Chahal M, Xu Y, Lesniak D, Graham K, Famulski K, Christensen JG, Aghi M, Jacques A, Murray D, Sabri S, Abdulkarim B.

Neuro Oncol. 2010 Aug;12(8):822-33. doi: 10.1093/neuonc/noq017. Epub 2010 Feb 23.

43.

Beta1-integrin circumvents the antiproliferative effects of trastuzumab in human epidermal growth factor receptor-2-positive breast cancer.

Lesniak D, Xu Y, Deschenes J, Lai R, Thoms J, Murray D, Gosh S, Mackey JR, Sabri S, Abdulkarim B.

Cancer Res. 2009 Nov 15;69(22):8620-8. doi: 10.1158/0008-5472.CAN-09-1591. Epub 2009 Nov 3.

44.

Assessment of tumor angiogenesis as a prognostic factor of survival in patients with oligodendroglioma.

Quon H, Hasbini A, Cougnard J, Djafari L, Lacroix C, Abdulkarim B.

J Neurooncol. 2010 Jan;96(2):277-85. doi: 10.1007/s11060-009-9961-x. Epub 2009 Jul 19.

PMID:
19618120
45.

Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas.

Quon H, Abdulkarim B.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD007104. doi: 10.1002/14651858.CD007104. Review. Update in: Cochrane Database Syst Rev. 2014;5:CD007104.

PMID:
18425979
46.

Skin-sparing radiation using intensity-modulated radiotherapy after conservative surgery in early-stage breast cancer: a planning study.

Saibishkumar EP, MacKenzie MA, Severin D, Mihai A, Hanson J, Daly H, Fallone G, Parliament MB, Abdulkarim BS.

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):485-91. Epub 2007 Sep 19.

PMID:
17881140
47.

Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.

Alexander A, Murtha A, Abdulkarim B, Mehta V, Wheatley M, Murray B, Riauka T, Hanson J, Fulton D, McEwan A, Roa W.

Clin Invest Med. 2006 Oct;29(5):301-11.

PMID:
17144440
48.

Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer.

Gabos Z, Sinha R, Hanson J, Chauhan N, Hugh J, Mackey JR, Abdulkarim B.

J Clin Oncol. 2006 Dec 20;24(36):5658-63. Epub 2006 Nov 13.

PMID:
17102066
49.

Cidofovir administered with radiation displays an antiangiogenic effect mediated by E6 inhibition and subsequent TP53-dependent VEGF repression in HPV18+ cell lines.

Amine A, Vozenin-Brotons MC, Abdulkarim B, Violot D, Aubel C, Bourhis J.

Radiat Res. 2006 Oct;166(4):600-10.

PMID:
17007547
50.

Radiotherapeutical innovations in pediatric solid tumors.

Habrand JL, Abdulkarim B, Roberti H.

Pediatr Blood Cancer. 2004 Nov;43(6):622-8. Review.

PMID:
15390311

Supplemental Content

Loading ...
Support Center